title: Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis.
authors.forename: Tjalke A
authors.initials: TA
authors.lastname: Westra
authors.forename: Mehraj B Y
authors.initials: MB
authors.lastname: Parouty
authors.forename: Jan C
authors.initials: JC
authors.lastname: Wilschut
authors.forename: Cornelis
authors.initials: C
authors.lastname: Boersma
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: Postma
mesh_terms: D005260:Female; D006801:Humans; D015233:Models, Statistical; D053918:Papillomavirus Vaccines / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000453:epidemiology*
chemical_list: D053918:Papillomavirus Vaccines